NYSE:BAXMedical Equipment
Baxter International (BAX): Assessing Valuation After Hemopatch Launch Sparks Investor Interest
Baxter International (BAX) just introduced its new Hemopatch sealing hemostat, a product built with direct input from surgeons to better meet real-world needs in both open and minimally invasive procedures. This announcement follows years of close collaboration between experts and developers and highlights Baxter’s focus on practical innovation that aims to make a difference for both patients and surgical teams. Although it may seem like another addition to Baxter’s broad portfolio, the...